Other Tumors

  • Michael T. Mazur
  • Robert J. Kurman
Chapter

Uterine tumors other than benign polyps or carcinoma are rarely encountered in endometrial biopsies and curettings. The classification in Table 11.1 lists most of these other neoplasms. Among this group of tumors, malignant= mixed mesodermal tumor (MMMT) is the most common malignancy, yet it accounts for only 1% to 2% of all uterine neoplasms. MMMT typically arises in the endometrium and is often first diagnosed by biopsy or curettage. The remaining tumors are extremely infrequent in endometrial curettings. Even submucosal leiomyomas rarely are sampled by an endometrial biopsy or curettage. It has been reported that prior to a hysterectomy the diagnosis of endometrial stromal sarcoma is missed in 20% of cases.

Keywords

Stromal Tumor Endometrial Stromal Sarcoma Uterine Corpus Alveolar Soft Part Sarcoma Malignant Mixed Mullerian Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    Zaloudek CJ, Hendrickson MR. Mesenchymal tumors of the uterus. In: Kurman RJ, ed. Blaustein’s pathology of the female genital tract. New York: Springer-Verlag; 2002: 5th ed. 561–615.Google Scholar
  2. (2).
    Clement PB. Tumorlike lesions of the uterine corpus. In: Clement PB, Young RH, eds. Tumors and tumorlike lesions of the uterine corpus and cervix. New York: Churchill Livingstone; 1993: 137–179.Google Scholar
  3. (3).
    Clement PB, Scully RE. Tumors with mixed epithelial and mesenchymal elements. In: Clement PB, Young RH, eds. Tumors and tumorlike lesions of the uterine corpus and cervix. New York: Churchill Livingstone; 1993: 329–370.Google Scholar
  4. (4).
    DiSaia PJ, Creasman WT. Clinical gynecologic oncology, 6th ed. St. Louis: Mosby-Year Book, 2002.Google Scholar
  5. (5).
    Goff BA, Rice LW, Fleischhacker D, Muntz HG, Falkenberry SS, Nikrui N, et al. Uterine leiomyosarcoma and endometrial stromal sarcoma: Lymph node metastases and sites of recurrence. Gynecol Oncol 1993; 50:105–109.PubMedCrossRefGoogle Scholar
  6. (6).
    Leibsohn S, d’Ablaing G, Mishell DRJ, Schlaerth JB. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol 1990; 162:968–976.PubMedGoogle Scholar
  7. (7).
    Kahanpaa KV, Wahlstrom T, Grohn P, Heinonen E, Nieminen U, Widholm O. Sarcomas of the uterus: A clinicopathologic study of 119 patients. Obstet Gynecol 1986; 67:417–424.PubMedGoogle Scholar
  8. (8).
    Kounelis S, Jones MW, Papadaki H, Bakker A, Swalsky P, Finkelstein SD. Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: Comparative molecular analysis of epithelial and mesenchymal components. Hum Pathol 1998; 29:82–87.PubMedCrossRefGoogle Scholar
  9. (9).
    Thompson L, Chang B, Barsky SH. Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol 1996; 20: 277–285.PubMedCrossRefGoogle Scholar
  10. (10).
    Wada H, Enomoto T, Fujita M, Yoshino K, Nakashima R, Kurachi H, et al. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors. Cancer Res 1997; 57:5379–5385.PubMedGoogle Scholar
  11. (11).
    Debrito PA, Silverberg SG, Orenstein JM. Carcinosarcoma (malignant mixed mullerian (mesodermal) tumor) of the female genital tract—immunohistochemical and ultrastructural analysis of 28 cases. Hum Pathol 1993; 24:132–142.CrossRefGoogle Scholar
  12. (12).
    Silverberg SG, Major FJ, Blessing JA, Fetter B, Askin FB, Liao S-Y, et al. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol 1990; 9:1–19.PubMedCrossRefGoogle Scholar
  13. (13).
    Bitterman P, Chun B, Kurman RJ. The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study. Am J Surg Pathol 1990; 14:317–328.PubMedGoogle Scholar
  14. (14).
    George E, Manivel JC, Dehner LP, Wick MR. Malignant mixed mullerian tumors: An immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation. Hum Pathol 1991; 22:215–223.PubMedCrossRefGoogle Scholar
  15. (15).
    Meis JM, Lawrence WD. The immunohistochemical profile of malignant mixed mullerian tumor. Overlap with endometrial adenocarcinoma. Am J Clin Pathol 1990; 94:1–7.PubMedGoogle Scholar
  16. (16).
    Colombi RP. Sarcomatoid carcinomas of the female genital tract (malignant mixed mullerian tumors). Semin Diagn Pathol 1993; 10:169–175.PubMedGoogle Scholar
  17. (17).
    Zelmanowicz A, Hildesheim A, Sherman ME, Sturgeon SR, Kurman RJ, Barrett RJ, et al. Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors. Gynecol Oncol 1998; 69: 253–257.PubMedCrossRefGoogle Scholar
  18. (18).
    Sreenan JJ, Hart WR. Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: Further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis. Am J Surg Pathol 1995; 19(6):666–674.PubMedGoogle Scholar
  19. (19).
    Geisinger KR, Dabbs DJ, Marshall RB. Malignant mixed mullerian tumors. An ultrastructural and immunohistochemical analysis with histogenetic considerations. Cancer 1987; 59: 1781–1790.PubMedCrossRefGoogle Scholar
  20. (20).
    Auerbach HE, Livolsi VA, Merino MJ. Malignant mixed mullerian tumors of the uterus. An immunohistochemical study. Int J Gynecol Pathol 1988; 7:123–130.PubMedGoogle Scholar
  21. (21).
    Dinh TV, Slavin RE, Bhagavan BS, Hannigan EV, Tiamson EM, Yandell RB. Mixed mullerian tumors of the uterus. A clinicopathologic study. Obstet Gynecol 1989; 74:388–392.PubMedGoogle Scholar
  22. (22).
    Silverberg SG, Kurman RJ. Tumors of the uterine corpus and gestational trophoblastic disease. Atlas of tumor pathology, 3rd series, Fascicle 3. Washington, DC: Armed Forces Institute of Pathology, 1992.Google Scholar
  23. (23).
    Norris HJ, Roth E, Taylor HB. Mesenchymal tumors of the uterus. II. A clinical and pathologic study of 31 mixed mesodermal tumors. Obstet Gynecol 1966; 28:57–63.PubMedGoogle Scholar
  24. (24).
    Norris HJ, Taylor HB. Mesenchymal tumors of the uterus. III. A clinical and pathologic study of 31 carcinosarcomas. Cancer 1966; 19:1459–1465.PubMedCrossRefGoogle Scholar
  25. (25).
    Gagne H, Tetu B, Blondeau L, Raymond PE, Blais R. Morphologic prognostic factors of malignant mixed mullerian tumor of the uterus: A clinicopathologic study of 58 cases. Mod Pathol 1989; 2:433–438.PubMedGoogle Scholar
  26. (26).
    Schweizer W, Demopoulos R, Beller U, Dubin H. Prognostic factors for malignant mixed mullerian tumors of the uterus. Int J Gynecol Pathol 1990; 9:129–136.PubMedCrossRefGoogle Scholar
  27. (27).
    Young RH, Kleinman GM, Scully RE. Glioma of the uterus. Report of a case with comments on histogenesis. Am J Surg Pathol 1981; 5:695–699.PubMedCrossRefGoogle Scholar
  28. (28).
    Gersell DJ, Duncan DA, Fulling KH. Malignant mixed mullerian tumor of the uterus with neuroectodermal differentiation. Int J Gynecol Pathol 1989; 8:169–178.PubMedCrossRefGoogle Scholar
  29. (29).
    Azumi N, Czernobilsky B. Immunohistochemistry. In: Kurman RJ, ed. Blaustein’s pathology of the female genital tract. New York: Springer-Verlag’ 5th ed. 2002: 1251–1276.Google Scholar
  30. (30).
    Cerilli LA, Wick MR. Immunohistology of soft tissue and osseous neoplasms. In: Dabbs DJ, ed. Diagnostic immunohistochemistry. Philadelphia: Churchill Livingstone; 2002: 59–112.Google Scholar
  31. (31).
    Clement PB, Oliva E, Young RH. Mullerian adenosarcoma of the uterine corpus associated with tamoxifen therapy: A report of six cases and a review of tamoxifen-associated endometrial lesions. Int J Gynecol Pathol 1996; 15:222–229.PubMedCrossRefGoogle Scholar
  32. (32).
    Clement PB, Scully RE. Mullerian adenosarcoma of the uterus: A clinicopatholgical analysis of 100 cases with a review of the literature. Hum Pathol 1990; 21:363–381.PubMedCrossRefGoogle Scholar
  33. (33).
    Clement PB, Scully RE. Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of ten cases of a distinctive type of Mullerian mixed tumor. Cancer 1974; 34: 1138–1149.PubMedCrossRefGoogle Scholar
  34. (34).
    Zaloudek CJ, Norris HJ. Adenofibroma and adenosarcoma of the uterus. A clinicopathologic study of 35 cases. Cancer 1981; 48: 354–366.PubMedCrossRefGoogle Scholar
  35. (35).
    Kaku T, Silverberg SG, Major FJ, Miller A, Fetter B, Brady MF. Adenosarcoma of the uterus: A Gynecologic Oncology Group clinicopathologic study of 31 cases. Int J Gynecol Pathol 1992; 11:75–88.PubMedCrossRefGoogle Scholar
  36. (36).
    Abell MR. Papillary adenofibroma of the uterine cervix. Am J Obstet Gynecol 1971; 110:990–993.PubMedGoogle Scholar
  37. (37).
    Vellios F, Ng AB, Reagan JW. Papillary adenofibroma of the uterus. A benign mesodermal mixed tumor of mullerian origin. Am J Clin Pathol 1973; 60:543–551.PubMedGoogle Scholar
  38. (38).
    Bocklage T, Lee KR, Belinson JL. Uterine mullerian adenosarcoma following adenomyoma in a woman on tamoxifen therapy. Gynecol Oncol 1992; 44:104–109.PubMedCrossRefGoogle Scholar
  39. (39).
    Kerner H, Lichtig C. Mullerian adenosarcoma presenting as cervical polyps-a report of seven cases and review of the literature. Obstet Gynecol 1993; 81:655–659.PubMedGoogle Scholar
  40. (40).
    Clement PB. Mullerian adenosarcomas of the uterus with sarcomatous overgrowth. A clinicopathological analysis of 10 cases. Am J Surg Pathol 1989; 13:28–38.PubMedCrossRefGoogle Scholar
  41. (41).
    Clement PB, Scully RE. Mullerian adenosarcomas of the uterus with sex cord-like elements. Am J Clin Pathol 1989; 91:664–672.PubMedGoogle Scholar
  42. (42).
    Tavassoli FA, Norris HJ. Mesenchymal tumors of the uterus. VII. A clinicopathologic study of 60 endometrial stromal nodules. Histopathology 1981; 5:1–10.PubMedCrossRefGoogle Scholar
  43. (43).
    Chang KL, Crabtree GS, Lim-Tan SK, Kempson RL, Hendrickson MR. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 1990; 14:415–438.PubMedCrossRefGoogle Scholar
  44. (44).
    Hart WR, Yoonessi M. Endometrial stromatosis of the uterus. Obstet Gynecol 1977; 49:393–403.PubMedGoogle Scholar
  45. (45).
    Norris HJ, Taylor HB. Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer 1966; 19:755–766.PubMedCrossRefGoogle Scholar
  46. (46).
    Yoonessi M, Hart WR. Endometrial stromal sarcomas. Cancer 1977; 40:898–906.PubMedCrossRefGoogle Scholar
  47. (47).
    Clement PB. Pure mesenchymal tumors. In: Clement PB, Young RH, eds. Tumors and tumorlike lesions of the uterine corpus and cervix. New York: Churchill Livingstone; 1993: 265–328.Google Scholar
  48. (48).
    Fekete PS, Vellios F. The clinical and histologic spectrum of endometrial stromal neoplasms: A report of 41 cases. Int J Gynecol Pathol 1984; 3:198–212.PubMedCrossRefGoogle Scholar
  49. (49).
    Evans HL. Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 1982; 50:2170–2182.PubMedCrossRefGoogle Scholar
  50. (50).
    Piver MS, Rutledge FN, Copeland L, Webster K, Blumenson L, Suh O. Uterine endolymphatic stromal myosis: A collaborative study. Obstet Gynecol 1984; 64:173–178.PubMedGoogle Scholar
  51. (51).
    Mansi JL, Ramachandra S, Wiltshaw E, Fisher C. Endometrial stromal sarcomas. Gynecol Oncol 1990; 36:113–118.PubMedCrossRefGoogle Scholar
  52. (52).
    Larson B, Silfversward C, Nilsson B, Pettersson F. Endometrial stromal sarcoma of the uterus. A clinical and histopathologic study. The Radiumhemmet series 1936–1981. Eur J Obstet Gynecol Reprod Biol 1990; 35:239–249.PubMedCrossRefGoogle Scholar
  53. (53).
    Gloor E, Schnyder P, Cikes M, et al. Endolymphatic stromal myosis: surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy. Cancer 1982; 50:1888–1893.PubMedCrossRefGoogle Scholar
  54. (54).
    Thatcher SS, Woodruff JD. Uterine stromatosis: A report of 33 cases. Obstet Gynecol 1982; 59:428–434.PubMedGoogle Scholar
  55. (55).
    Oliva E, Young RH, Clement PB, Bhan AK, Scully RE. Cellular benign mesenchymal tumors of the uterus. A comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and six endometrial stromal nodules, two frequently confused tumors. Am J Surg Pathol 1995; 19:757–768.PubMedCrossRefGoogle Scholar
  56. (56).
    Oliva E, Clement PB, Young RH. Endometrial stromal tumors: An update on a group of tumors with a protean phenotype. Adv Anat Pathol 2000; 7:257–281.PubMedCrossRefGoogle Scholar
  57. (57).
    Oliva E, Young RH, Amin MB, Clement PB. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: A study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol 2002; 26: 403–412.PubMedCrossRefGoogle Scholar
  58. (58).
    Agoff SN, Grieco VS, Garcia R, Gown AM. Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma. Appl Immunohistochem Mol Morphol 2001; 9:164–169.PubMedCrossRefGoogle Scholar
  59. (59).
    Farhood AI, Abrams J. Immunohistochemistry of endometrial stromal sarcoma. Hum Pathol 1991; 22:224–230.PubMedCrossRefGoogle Scholar
  60. (60).
    Lillemoe TJ, Perrone T, Norris HJ, Dehner LP. Myogenous phenotype of epithelial-like areas in endometrial stromal sarcomas. Arch Pathol Lab Med 1991; 115:215–219.PubMedGoogle Scholar
  61. (61).
    McCluggage WG, Sumathi VP, Maxwell P. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology 2001; 39:273–278.PubMedCrossRefGoogle Scholar
  62. (62).
    Chu PG, Arber DA, Weiss LM, Chang KL. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: An immunohistochemical comparison of 34 cases. Mod Pathol 2001; 14:465–471.PubMedCrossRefGoogle Scholar
  63. (63).
    Binder SW, Nieberg RK, Cheng L, al Jitawi S. Histologic and immunohistochemical analysis of nine endometrial stromal tumors: An unexpected high frequency of keratin protein positivity. Int J Gynecol Pathol 1991; 10:191–197.PubMedCrossRefGoogle Scholar
  64. (64).
    Dionigi A, Oliva E, Clement PB, Young RH. Endometrial stromal nodules and endometrial stromal tumors with limited infiltration: A clinicopathologic study of 50 cases. Am J Surg Pathol 2002; 26:567–581.PubMedCrossRefGoogle Scholar
  65. (65).
    Clement PB, Scully RE. Uterine tumors resembling ovarian sex-cord tumors. A clinicopathologic analysis of fourteen cases. Am J Clin Pathol 1976; 66:512–525.PubMedGoogle Scholar
  66. (66).
    McCluggage WG, Shah V, Walsh MY, Toner PG. Uterine tumour resembling ovarian sex cord tumour—evidence for smooth muscle differentiation. Histopathology 1993; 23:83–85.PubMedCrossRefGoogle Scholar
  67. (67).
    McCluggage WG, Date A, Bharucha H, Toner PG. Endometrial stromal sarcoma with sex cord-like areas and focal rhabdoid differentiation. Histopathology 1996; 29:369–374.PubMedCrossRefGoogle Scholar
  68. (68).
    Oliva E, Clement PB, Young RH. Epithelioid endometrial and endometrioid stromal tumors: A report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors. Int J Gynecol Pathol 2002; 21:48–55.PubMedCrossRefGoogle Scholar
  69. (69).
    Clement PB, Scully RE. Endometrial stromal sarcomas of the uterus with extensive endometrioid glandular differentiation: A report of three cases that caused problems in differential diagnosis. Int J Gynecol Pathol 1992; 11:163–173.PubMedCrossRefGoogle Scholar
  70. (70).
    Oliva E, Clement PB, Young RH, Scully RE. Mixed endometrial stromal and smooth muscle tumors of the uterus: A clinicopathologic study of 15 cases. Am J Surg Pathol 1998; 22:997–1005.PubMedCrossRefGoogle Scholar
  71. (71).
    Nucci MR, O’Connell JT, Huettner PC, Cviko A, Sun D, Quade BJ. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol 2001; 25:455–463.PubMedCrossRefGoogle Scholar
  72. (72).
    Deligdisch L, Loewenthal M. Endometrial changes associated with myomata of the uterus. J Clin Pathol 1970; 23:676–680.CrossRefGoogle Scholar
  73. (73).
    Kempson RL, Hendrickson MR. Pure mesenchymal neoplasms of the uterine corpus: selected problems. Semin Diagn Pathol 1988; 5:172–198.PubMedGoogle Scholar
  74. (74).
    Clement PB. Pathology of the uterine corpus. Hum Pathol 1991; 22:776–791.PubMedCrossRefGoogle Scholar
  75. (75).
    Evans HL, Chawla SP, Simpson C, et al. Smooth muscle tumors of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer 1988; 62:2239–2247.PubMedCrossRefGoogle Scholar
  76. (76).
    Prayson RA, Hart WR. Mitotically active leiomyomas of the uterus. Am J Clin Pathol 1992; 97:14–20.PubMedGoogle Scholar
  77. (77).
    O’Connor DM, Norris HJ. Mitotically active leiomyomas of the uterus. Hum Pathol 1990; 21:223–227.PubMedCrossRefGoogle Scholar
  78. (78).
    Hendrickson MR, Longacre TA, Kempson RL. The uterine corpus. In: Sternberg SS, ed. Diagnostic surgical pathology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins’ 1999: 2203–2305.Google Scholar
  79. (79).
    Kurman RJ, Norris HJ. Mesenchymal tumors of the uterus. VI. Epithelioid smooth muscle tumors including leiomyoblastoma and clear cell leiomyoma. Cancer 1976; 37:1853–1865.PubMedCrossRefGoogle Scholar
  80. (80).
    Mazur MT, Kraus FT. Histogenesis of morphologic variations in tumors of the uterine wall. Am J Surg Pathol 1980; 4:59–74.PubMedCrossRefGoogle Scholar
  81. (81).
    Perrone T, Dehner LP. Prognostically favorable “mitotically active” smooth-muscle tumors of the uterus. A clinicopathologic study of 10 cases. Am J Surg Pathol 1988; 12:1–8.PubMedCrossRefGoogle Scholar
  82. (82).
    Kaminski PF, Tavassoli FA. Plexiform tumorlet: A clinical and pathologic study of 15 cases with ultrastructural observations. Int J Gynecol Pathol 1984; 3:124–134.PubMedCrossRefGoogle Scholar
  83. (83).
    Taylor HB, Norris HJ. Mesenchymal tumors of the uterus. IV. Diagnosis and prognosis of leiomyosarcomas. Arch Pathol 1966; 82:40–44.PubMedGoogle Scholar
  84. (84).
    Kempson RL, Hendrickson MR. Pure mesenchymal neoplasms of the uterine corpus: selected problems. Semin Diagn Pathol 1988; 5:172–198.PubMedGoogle Scholar
  85. (85).
    Harris N, Scully R. Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. A clinicopathologic analysis of 27 cases. Cancer 1984; 53:2530–2545.PubMedCrossRefGoogle Scholar
  86. (86).
    Ferry JA, Young RH. Malignant lymphoma, pseudolymphoma, and hematopoietic disorders of the female genital tract. Pathol Annu 1991; 26:227–263.PubMedGoogle Scholar
  87. (87).
    Vang R, Medeiros LJ, Ha CS, Deavers M. Non-Hodgkin’s lymphomas involving the uterus: A clinicopathologic analysis of 26 cases. Mod Pathol 2000; 13:19–28.PubMedCrossRefGoogle Scholar
  88. (88).
    Clement PB. Miscellaneous primary neoplasms and metastatic neoplasms. In: Clement PB, Young RH, eds. Tumors and tumorlike lesions of the uterine corpus and cervix. New York: Churchill Livingstone; 1993: 371–418.Google Scholar
  89. (89).
    Masunaga A, Abe M, Tsujii E, Suzuki Y, Ohgida T, Toyama M, et al. Primary uterine T-cell lymphoma. Int J Gynecol Pathol 1998; 17:376–379.PubMedCrossRefGoogle Scholar
  90. (90).
    van de R M, Kamel OW, Chang PP, Lee A, Warnke RA, Salhany KE. Primary low-grade endometrial B-cell lymphoma. Am J Surg Pathol 1997; 21:187–194.CrossRefGoogle Scholar
  91. (91).
    Young RH, Harris NL, Scully RE. Lymphoma-like lesions of the lower female genital tract. A report of 16 cases. Int J Gynecol Pathol 1985; 4:289–299.PubMedCrossRefGoogle Scholar
  92. (92).
    Vakiani M, Mawad J, Talerman A. Heterologous sarcomas of the uterus. Int J Gynecol Pathol 1982; 1:211–219.PubMedCrossRefGoogle Scholar
  93. (93).
    De Young B, Bitterman P, Lack EE. Primary osteosarcoma of the uterus: Report of a case with immunohistochemical study. Mod Pathol 1992; 5:212–215.PubMedGoogle Scholar
  94. (94).
    Clement PB. Chondrosarcoma of the uterus: Report of a case and review of the literature. Hum Pathol 1978; 6:726–727.CrossRefGoogle Scholar
  95. (95).
    Chiarle R, Godio L, Fusi D, Soldati T, Palestro G. Pure alveolar rhabdomyosarcoma of the corpus uteri: Description of a case with increased serum level of CA-125. Gynecol Oncol 1997; 66:320–323.PubMedCrossRefGoogle Scholar
  96. (96).
    Holcomb K, Francis M, Ruiz J, Abulafia O, Matthews RP, Lee YC. Pleomorphic rhabdomyosarcoma of the uterus in a postmenopausal woman with elevated serum CA125. Gynecol Oncol 1999; 74:499–501.PubMedCrossRefGoogle Scholar
  97. (97).
    McCluggage WG, Lioe TF, McClelland HR, Lamki H. Rhabdomyosarcoma of the uterus: Report of two cases, including one of the spindle cell variant. Int J Gynecol Cancer 2002; 12:128–132.PubMedCrossRefGoogle Scholar
  98. (98).
    Ordi J, Stamatakos MD, Tavassoli FA. Pure pleomorphic rhabdomyosarcomas of the uterus. Int J Gynecol Pathol 1997; 16:369–377.PubMedCrossRefGoogle Scholar
  99. (99).
    Schammel DP, Tavassoli FA. Uterine angiosarcomas: A morphologic and immunohistochemical study of four cases. Am J Surg Pathol 1998; 22:246–250.PubMedCrossRefGoogle Scholar
  100. (100).
    Guillou L, Lamoureux E, Masse S, Costa J. Alveolar soft-part sarcoma of the uterine corpus: Histological, immunocytochemical and ultrastructural study of a case. Virchows Archiv [A] Pathol Anat 1991; 418:467–471.CrossRefGoogle Scholar
  101. (101).
    Cho KR, Rosenchein NB, Epstein JI. Malignant rhabdoid tumor of the uterus. Int J Gynecol Pathol 1989; 8:381–387.PubMedCrossRefGoogle Scholar
  102. (102).
    Gray GJ, Glick A, Kurtin P, Jones H. Alveolar soft part sarcoma of the uterus. Hum Pathol 1986; 17:297–300.PubMedCrossRefGoogle Scholar
  103. (103).
    Nolan N, Gaffney E. Alveolar soft part sarcoma of the uterus. Histopathology 1990; 16:97–99.PubMedCrossRefGoogle Scholar
  104. (104).
    Radig K, Buhtz P, Roessner A. Alveolar soft part sarcoma of the uterine corpus. Report of two cases and review of the literature. Pathol Res Pract 1998; 194:59–63.PubMedGoogle Scholar
  105. (105).
    Gaertner EM, Farley JH, Taylor RR, Silver SA. Collision of uterine rhabdoid tumor and endometrioid adenocarcinoma: A case report and review of the literature. Int J Gynecol Pathol 1999; 18:396–401.PubMedCrossRefGoogle Scholar
  106. (106).
    Joseph MG, Fellows FG, Hearn SA. Primary endodermal sinus tumor of the endometrium. A clinicopathologic, immunocytochemical, and ultrastructural study. Cancer 1990; 63: 297–302.CrossRefGoogle Scholar
  107. (107).
    Ohta M, Sakakibara K, Mizuno K, Kano T, Matsuzawa K, Tomoda Y, et al. Successful treatment of primary endodermal sinus tumor of the endometrium. Gynecol Oncol 1988; 31: 357–364.PubMedCrossRefGoogle Scholar
  108. (108).
    Martin E, Scholes J, Richart R, Fenoglio C. Benign cystic teratoma of the uterus. Am J Obstet Gynecol 1979; 135:429–431.PubMedGoogle Scholar
  109. (109).
    Daya D, Lukka H, Clement PB. Primitive neuroectodermal tumors of the uterus—A report of four cases. Hum Pathol 1992; 23:1120–1129.PubMedCrossRefGoogle Scholar
  110. (110).
    Hendrickson MR, Scheithauer BW. Primitive neuroectodermal tumor of the endometrium: Report of two cases, one with electron microscopic observations. Int J Gynecol Pathol 1986; 5:249–259.PubMedCrossRefGoogle Scholar
  111. (111).
    Beham A, Schmid C, Fletcher CDM, Aubock L, Pickel H. Malignant paraganglioma of the uterus. Virchows Arch [A] 1992; 420:453–457.CrossRefGoogle Scholar
  112. (112).
    Tavassoli F. Melanotic paraganglioma of the uterus. Cancer 1986; 58:942–948.PubMedCrossRefGoogle Scholar
  113. (113).
    Young TW, Thrasher TV. Nonchromaffin paraganglioma of the uterus. Arch Pathol Lab Med 1982; 106:608–609.PubMedGoogle Scholar
  114. (114).
    Bittencourt AL, Britto JF, Fonseca LEJ. Wilms’ tumor of the uterus: The first report of the literature. Cancer 1981; 47:2496–2499.PubMedCrossRefGoogle Scholar
  115. (115).
    Muc RS, Grayson W, Grobbelaar JJ. Adult extrarenal Wilms tumor occurring in the uterus. Arch Pathol Lab Med 2001; 125: 1081–1083.PubMedGoogle Scholar
  116. (116).
    Carlier MT, Dardick I, Lagace AF, Sreeram V. Adenomatoid tumor of the uterus: presentation in endometrial curettings. Int J Gynecol Pathol 1986; 5:69–74.PubMedCrossRefGoogle Scholar
  117. (117).
    Sherman ME, Mazur MT, Kurman RJ. Benign diseases of the endometrium. In: Kurman RJ, ed. Blaustein’s pathology of the female genital tract. 5th ed. New York: Springer-Verlag; 2002:421–466.Google Scholar
  118. (118).
    Alpert LC, Haufrect EJ, Schwartz MR. Uterine lithiasis. Am J Surg Pathol 1990; 14: 1071–1075.PubMedCrossRefGoogle Scholar
  119. (119).
    Herbold DR, Magrane DM. Calcifications of the benign endometrium. Arch Pathol Lab Med 1986; 110:666–669.PubMedGoogle Scholar
  120. (120).
    Untawale VG, Gabriel JB, Chauhan PM. Calcific endometritis. Am J Obstet Gynecol 1982; 144:482–483.PubMedGoogle Scholar
  121. (121).
    Ceccacci L, Clancy G. Endometrial ossification: Report of an additional case. Am J Obstet Gynecol 1981; 141:103–104.PubMedGoogle Scholar
  122. (122).
    Bhatia NN, Hoshiko MG. Uterine osseous metaplasia. Obstet Gynecol 1982; 60:256–259.PubMedGoogle Scholar
  123. (123).
    Waxman M, Moussouris HF. Endometrial ossification following an abortion. Am J Obstet Gynecol 1978; 130:587–588.PubMedGoogle Scholar
  124. (124).
    Valicenti JF, Priester SK. Psammoma bodies of benign endometrial origin in cervicovaginal cytology. Acta Cytol 1977; 21:550–552.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  • Michael T. Mazur
    • 1
    • 2
  • Robert J. Kurman
    • 3
    • 4
  1. 1.Upstate Medical UniversityState University of New YorkSyracuse
  2. 2.ClearPath DiagnosticsSyracuseUSA
  3. 3.Departments of Gynecology, Obstetrics and PathologyThe Johns Hopkins HospitalBaltimoreUSA
  4. 4.The Johns Hopkins University, School of MedicineBaltimoreUSA

Personalised recommendations